TrialBritish journal of cancer2023

Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10.

Rebecca S Kristeleit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.